While supplementation with exogenous GSH has shown therapeutic potential on its own, recent findings indicate advantages to combined treatment with other immunomodulatory or anti-infective agents ( As a combined medicinal treatment for viral infections such as COVID-19 or influenza, administration of GSH or NAC in conjunction with established anti-viral treatment has been found to improve lymphocyte response, reduce pro-inflammatory cytokines and reduce cellular oxidative injury ( As a pharmacologic therapeutic, optimizing the efficacy of GSH and minimizing its unintended effects means it is crucial to determine the correct timing, dose, and disease context ( In addition to being a therapeutic target, oxidative stress has been shown to decrease the GSH:GSSG ratio which has proven useful as a clinically accessible, pharmacodynamic biomarker of immune redox tone for conditions such as malignancy (Zitka et al., 2012)
GHK-Cu is key for fixing and growing new skin tissue
Stable expression, activity, and inducibility of cytochromes P450 in differentiated HepaRG cells
Endogenous hydrogen sulfide enhances cell proliferation of human gastric cancer AGS cells
These approaches complement injectable glutathione by reducing the oxidative burden created by chronic stress while supporting overall psychological and physiological resilience
Cystathione -synthase is increased in thyroid malignancies
